RT Journal Article
SR Electronic
T1 Dynamic Data-Driven Algorithm to Predict the Cumulative COVID-19 Infected Cases Using Susceptible-Infected-Susceptible Model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.24.21253599
DO 10.1101/2021.03.24.21253599
A1 Anand, Abhinav
A1 Kumar, Saurabh
A1 Ghosh, Palash
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.24.21253599.abstract
AB In recent times, researchers have used Susceptible-Infected-Susceptible (SIS) model to understand the spread of pandemic COVID-19. The SIS model has two compartments, susceptible and infected. In this model, the interest is to determine the number of infected people at a given time point. However, it is also essential to know the cumulative number of infected people at a given time point, which is not directly available from the SIS model’s present structure. In this work, we propose a modified structure of the SIS model to determine the cumulative number of infected people at a given time point. We develop a dynamic data-driven algorithm to estimate the model parameters based on an optimally chosen training phase to predict the same. We demonstrate the proposed algorithm’s prediction performance using COVID-19 data from Delhi, India’s capital city.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not Required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have used open access data. The link to the source data has been mentioned in the manuscript. https://www.covid19india.org/